Article info

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
  1. Correspondence to:
    Dr A Kavanaugh
    Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0943, USA; akavanaughucsd.edu
View Full Text

Citation

Antoni C, Krueger GG, de Vlam K, et al
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Publication history

  • Accepted January 16, 2005
  • First published January 27, 2005.
Online issue publication 
July 12, 2005

Article Versions

  • Files in this Data Supplement:

    • view PDF - Infliximab migliora segni e sintomi dell�artrite psoriasica: risultati dello studio IMPACT 2.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.